With nearly 239,000 men in the United States diagnosed with prostate cancer in 2013, it is important to have a game plan for prevention, screening and treatment. View the infographic below for more:
ProstateCancer
New Findings May Change Treatment of Advanced Prostate Cancer
For about 70 years, the standard treatment for patients with advanced prostate cancer was drugs that blocked male hormones feeding the tumor. If that stopped working and the disease progressed, oncologists turned to chemotherapy to kill the cancer cells.
This timetable is about to change. Results of a clinical trial led by a Dana-Farber researcher revealed that such patients lived longer if started on both a hormone blocker and a chemotherapy drug at the same time. The government-sponsored trial found that 69 percent of men receiving both treatments were alive at three years, compared with 52.5 percent of men who initially got just the hormone blocker. The advantage was so striking – especially for patients with greater degrees of cancer spread – that the National Cancer Institute publicized the findings ahead of schedule to alert doctors and patients.
“The results of this study are practice-changing for some patients,” says Christopher Sweeney, MBBS, clinical director of Dana-Farber’s Lank Center for Genitourinary Cancer, who headed the trial. We asked him to explain:
Can a Vasectomy Increase a Man’s Risk of Prostate or Testicular Cancer?
There has been some uncertainty surrounding this question, but recent studies have demonstrated that having a vasectomy has no effect on the risk of prostate or testicular cancer.
Older data – from studies tracking disease rates across broad population groups – suggested a modest connection, while other studies found no such link.
Why It’s Important to See a Specialist
In January 2012, my wife and I had left Boston to spend a few months in sunny Florida. We had just passed Orlando when my cell phone rang. It was my primary care physician calling to tell me she was concerned that my PSA was elevated to 6, which showed that I did have a problem with my prostate.
This is where it all started.
Who Should Have PSA Testing For Prostate Cancer?
Millions of men each year have their blood tested to determine their levels of prostate specific antigen (PSA), a normal protein. Levels may be elevated in men with prostate cancer or other benign diseases of the prostate. However, experts have disagreed on who should be tested, when, and how frequently. Some are concerned about whether … Read more
Proton Therapy No Better Than Traditional Therapy for Prostate Cancer Patients
This post was originally published in December 2012.
When it comes to treating prostate cancer, proton radiotherapy (PRT) is no better than traditional intensity-modulated radiation therapy (IMRT), according to a new study reported in the Journal of the National Cancer Institute on Friday.
PRT is an advanced but expensive treatment option for some prostate cancer patients. However, the researchers found that the therapy offers no added treatment benefit than the standard therapy. The article concluded: “Although PRT is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment.”
Prostate cancer: At what age should you be screened?
What age is appropriate to get screened for prostate cancer and begin treatment? Recent news surrounding Warren Buffett’s diagnosis, including a report on Boston.com, has some asking if age should factor into these decisions. Dr. Philip Kantoff, chief of the Division of Solid tumor at Dana-Farber and director of Dana-Farber’s Lank Center for Genitourinary Oncology, speaks … Read more